COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,948 Articles (22,604 medRxiv, 8,344 bioRxiv)

Most recent first Previous |  Page 512: Articles 5111-5120  | Next

Streptococcus pneumoniae re-emerges as a cause of community-acquired pneumonia, including frequent co-infection with SARS-CoV-2, in Germany, 2021
Ankert, J., Hagel, S., Schwarz, C., Pan, K., Wang, L., von Eiff, C., Gessner, B. D., Theilacker, C., Pletz, M. W.
10.1101/2022.12.15.22282988 — Posted: 2022-12-16
Depression and its associated factors among COVID-19 survivors in a middle income country
Moy, F. M., Lim, E. R. J., Hairi, N. N., Bulgiba, A.
10.1101/2022.12.15.22283550 — Posted: 2022-12-16
Prevalence of salivary anti-SARS-CoV-2 IgG antibodies in vaccinated children
Badano, M. N., Duarte, A., Salamone, G., Sabbione, F., Pereson, M. J., Chuit, R., Bare, P.
10.1101/2022.12.15.22283480 — Posted: 2022-12-16
Local-Scale phylodynamics reveal differential community impact of SARS-CoV-2 in metropolitan US county
Paredes, M. I., Perofsky, A. C., Frisbie, L., Moncla, L., Roychoudhury, P., Xie, H., Mohamed Bakhash, S. A., Kong, K., Arnould, I., Nguyen, T. V., Wendm, S. T., Hajian, P., Ellis, S., Mathias, P. C., Greninger, A. L., Starita, L. M., Frazar, C. D., Ryke, E., Zhong, W., Gamboa, L., Threlkeld, M., Lee, J., Stone, J., McDermot, E., Truong, M., Shendure, J., Oltean, H. N., Viboud, C., Chu, H., Muller, N. F., Bedford, T.
10.1101/2022.12.15.22283536 — Posted: 2022-12-16
Impact of COVID-19 and the postponement of the Tokyo 2020 Paralympic Games on Paralympic athletes and staff: A cross-sectional study
Walter, M., Mesa, A., McCracken, L. A., Barakso, C., Bueno Buker, D., Benavides Gonzalez, P., Holtz, W., Jaeger, C., Nightingale, T. E., Krassioukov, A. V.
10.1101/2022.12.14.22283406 — Posted: 2022-12-16
Molecular identification of SARS-CoV-2 variants of concern at urban wastewater treatment plants across South Africa
Yousif, M., Rachida, S., Taukobong, S., Ndlovu, N., Iwu-Jaja, C., Howard, W., Moonsamy, S., Mhlambi, N., Gwala, S., Levy, J., Andersen, K., Scheepers, C., von Gottberg, A., Wolter, N. I., Ismail, A., Suchard, M., McCarthy, K.
10.1101/2022.12.15.22283506 — Posted: 2022-12-16
Estimating measures to reduce the transmission of SARS-CoV-2 in Australia to guide a 'National Plan' to reopening
Ryan, G. E., Shearer, F. M., McCaw, J., McVernon, J., Golding, N.
10.1101/2022.12.15.22282869 — Posted: 2022-12-16
SARS-CoV-2-associated mortality with a principal cause other than COVID-19 during the Omicron epidemic in France and detection and treatment of Omicron infections in associated complications
Goldstein, E.
10.1101/2022.12.15.22283529 — Posted: 2022-12-16
Synthesizing evidence on the impacts of COVID-19 regulatory changes on methadone treatment for opioid use disorder: Implications for U.S. federal policy
Krawczyk, N., Rivera, B. D., Levin, E., Dooling, B. C. E.
10.1101/2022.12.15.22283533 — Posted: 2022-12-16
Effect of Ivermectin 600 mcg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial
Naggie, S., Boulware, D. R., Lindsell, C. J., Stewart, T. G., Lim, S. C., Cohen, J., Kavtaradze, D., Amon, A. P., Gabriel, A., Gentile, N., Felker, G. M., Rothman, R. L., Jayaweera, D., McCarthy, M. W., Sulkowski, M., Wilson, S., DeLong, A., Remaly, A., Wilder, R., Collins, S., Dunsmore, S. E., Adam, S. J., Thicklin, F., Hanna, G., Ginde, A. A., Castro, M., McTigue, K., Shenkman, E., Hernandez, A. F.
10.1101/2022.12.15.22283488 — Posted: 2022-12-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).